Artiva Biotherapeutics, Inc.
ARTV- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817241
In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Artiva Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +49 vs. Q2 2024
- Shares held
- 20.7M
- +20.7M vs. Q2 2024
- Total value
- $319.4M
- +$319.4M vs. Q2 2024
- New holders
- 49
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $391.6M |
| Q1 2026 | 40 | $108.4M |
| Q4 2025 | 34 | $72.7M |
| Q3 2025 | 40 | $52.1M |
| Q2 2025 | 48 | $27.9M |
| Q1 2025 | 53 | $62.8M |
| Q4 2024 | 57 | $213.2M |
| Q3 2024 | 49 | $319.4M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Artiva Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 9,853,302 | $152.2M | 1.76% | +9,853,302 | New |
| 5AM Venture Management, LLC | 2,353,304 | $36.4M | 7.51% | +2,353,304 | New |
| VR Adviser, LLC | 1,609,569 | $24.9M | 1.30% | +1,609,569 | New |
| venBio Partners LLC | 1,519,971 | $23.5M | 12.08% | +1,519,971 | New |
| Capital World Investors | 915,386 | $14.1M | 0.00% | +915,386 | New |
| Vanguard Group Inc | 841,005 | $13.0M | 0.00% | +841,005 | New |
| BlackRock, Inc. | 837,613 | $12.9M | 0.00% | +837,613 | New |
| Franklin Resources Inc | 520,301 | $7.44M | 0.00% | +520,301 | New |
| Geode Capital Management, LLC | 308,930 | $4.77M | 0.00% | +308,930 | New |
| Samsara BioCapital, LLC | 291,666 | $4.51M | 0.87% | +291,666 | New |
| Woodline Partners LP | 283,124 | $4.37M | 0.04% | +283,124 | New |
| Wellington Management Group LLP | 194,108 | $2.91M | 0.00% | +194,108 | New |
| RTW Investments, LP | 148,844 | $2.30M | 0.03% | +148,844 | New |
| Logos Global Management LP | 145,089 | $2.13M | 0.24% | +145,089 | New |
| Northern Trust Corp | 112,777 | $1.74M | 0.00% | +112,777 | New |
| Cormorant Asset Management, LP | 103,633 | $1.60M | 0.08% | +103,633 | New |
| Alyeska Investment Group, L.P. | 100,000 | $1.54M | 0.01% | +100,000 | New |
| Citadel Advisors LLC | 103,635 | $1.52M | 0.00% | +103,635 | New |
| State Street Corp | 86,559 | $1.34M | 0.00% | +86,559 | New |
| Acuta Capital Partners, LLC | 44,000 | $679.8K | 0.55% | +44,000 | New |
| EcoR1 Capital, LLC | 41,453 | $640.4K | 0.02% | +41,453 | New |
| Charles Schwab Investment Management Inc | 40,293 | $622.5K | 0.00% | +40,293 | New |
| Morgan Stanley | 39,953 | $617.3K | 0.00% | +39,953 | New |
| Bank of New York Mellon Corp | 31,209 | $482.2K | 0.00% | +31,209 | New |
| Norges Bank | 30,000 | $463.5K | 0.00% | +30,000 | New |
| Goldman Sachs Group Inc | 29,547 | $456.5K | 0.00% | +29,547 | New |
| Barclays PLC | 19,616 | $303.1K | 0.00% | +19,616 | New |
| Nuveen Asset Management, LLC | 18,611 | $287.5K | 0.00% | +18,611 | New |
| Bank of America Corp | 17,818 | $275.3K | 0.00% | +17,818 | New |
| Rhumbline Advisers | 14,829 | $229.1K | 0.00% | +14,829 | New |
| JPMorgan Chase & Co | 10,726 | $165.7K | 0.00% | +10,726 | New |
| Citigroup Inc | 10,181 | $157.3K | 0.00% | +10,181 | New |
| MetLife Investment Management | 8,733 | $134.9K | 0.00% | +8,733 | New |
| Mirae Asset Global ETFs Holdings Ltd. | 7,659 | $118.3K | 0.00% | +7,659 | New |
| Corebridge Financial, Inc. | 7,515 | $116.1K | 0.00% | +7,515 | New |
| UBS Group AG | 6,618 | $102.2K | 0.00% | +6,618 | New |
| Wells Fargo & Company | 5,255 | $81.2K | 0.00% | +5,255 | New |
| New York State Common Retirement Fund | 2,937 | $45.4K | 0.00% | +2,937 | New |
| BNP Paribas Arbitrage, SA | 2,728 | $42.1K | 0.00% | +2,728 | New |
| STRS Ohio | 2,600 | $40.2K | 0.00% | +2,600 | New |
| Royal Bank of Canada | 2,061 | $32.0K | 0.00% | +2,061 | New |
| Ameritas Investment Partners, Inc. | 1,424 | $22.0K | 0.00% | +1,424 | New |
| Legal & General Group Plc | 1,393 | $21.5K | 0.00% | +1,393 | New |
| Mark Sheptoff Financial Planning, LLC | 1,300 | $20.1K | 0.01% | +1,300 | New |
| California State Teachers Retirement System | 1,041 | $16.1K | 0.00% | +1,041 | New |
| Tower Research Capital LLC (TRC) | 720 | $11.1K | 0.00% | +720 | New |
| Amalgamated Bank | 480 | $7.00K | 0.00% | +480 | New |
| FMR LLC | 160 | $2.47K | 0.00% | +160 | New |
| Sterling Capital Management LLC | 31 | $479 | 0.00% | +31 | New |